Christina U. Lorentz

1.0k citations

36 papers · 728 indexed · h-index 15

Genetics top 5%
Hematology top 5%
Cardiology and Cardiovascular Medicine top 10%
Molecular Biology
Immunology

Co-authors: Erik I. Tucker Owen J. T. McCarty David Gailani András Gruber Beth A. Habecker Monica T. Hinds Joseph J. Shatzel Cristina Puy
Topics: Blood Coagulation and Thrombosis Mechanisms (20 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers)Nerve injury and regeneration (5 papers)
Cited by: Genetics Hematology Internal Medicine
Journals: Journal of Biological Chemistry The Journal of Experimental Medicine The Journal of Cell Biology
Partner nations: United States Canada Denmark

In The Last Decade

Christina U. Lorentz

34 papers receiving 719 citations

Peers

Countries citing papers authored by Christina U. Lorentz

Since Specialization

Citations

This map shows the geographic impact of Christina U. Lorentz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina U. Lorentz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina U. Lorentz more than expected).

Fields of papers citing papers by Christina U. Lorentz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina U. Lorentz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina U. Lorentz. The network helps show where Christina U. Lorentz may publish in the future.

Co-authorship network of co-authors of Christina U. Lorentz

This figure shows the co-authorship network connecting the top 25 collaborators of Christina U. Lorentz. A scholar is included among the top collaborators of Christina U. Lorentz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina U. Lorentz. Christina U. Lorentz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo 2024 ·Blood ·Cristina Puy,(unknown),Jiaqing Pang,(unknown),(unknown),Christina U. Lorentz,Erik I. Tucker,Joseph J. Shatzel,Ravi S. Keshari,Florea Lupu,David Gailani,Owen J. T. McCarty	11
2	Role of platelet count in a murine stasis model of deep vein thrombosis 2023 ·Platelets ·(unknown),(unknown),(unknown),Andy Kaempf,Jennifer M. Loftis,R. L. Woltjer,Christina U. Lorentz,Alexey S. Revenko,Monica T. Hinds,Khanh P. Nguyen	5
3	PB0592 Evaluation of the Role of Skeletal Muscle Myosin as a Cofactor for Factor XI Activation of Factor XII 2023 ·Research and Practice in Thrombosis and Haemostasis ·Yang Cao,John H. Griffin,David Gailani,Erik I. Tucker,Christina U. Lorentz,Owen J. T. McCarty,Cristina Puy	1
4	OC 49.2 Pharmacological Targeting of the Contact Pathway Attenuates Experimental Autoimmune Encephalomyelitis in Mice 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),Marie Fallon,(unknown),Luke M. Healy,Christina U. Lorentz,Erik I. Tucker,Owen J. T. McCarty,David Gailani,Halina Offner,Norah G. Verbout	1
5	PB0700 FXI Inhibitor Safety in Hemophilia Patients: Computational Prediction of Thrombin Generation 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),(unknown),Cristina Puy,Shaojie Wang,Michael B. Fallon,Erik I. Tucker,Joseph J. Shatzel,Christina U. Lorentz,Owen J. T. McCarty,David Gailani	1
6	Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis 2022 ·Journal of Thrombosis and Haemostasis ·Kelley R. Jordan,Cory Wyatt,(unknown),Randy Woltjer,Edward A. Neuwelt,(unknown),David Gailani,Christina U. Lorentz,Erik I. Tucker,Owen J. T. McCarty,Monica T. Hinds,Khanh P. Nguyen	14
7	The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial 2021 ·Blood ·Christina U. Lorentz,Erik I. Tucker,Norah G. Verbout,Joseph J. Shatzel,Sven R. Olson,Brandon D. Markway,Michael Wallisch,Martina Ralle,Monica T. Hinds,Owen J. T. McCarty,David Gailani,Jeffrey I. Weitz,András Gruber	89
8	Factor XII plays a pathogenic role in organ failure and death in baboons challenged withStaphylococcus aureus 2021 ·Blood ·Robert Silasi‐Mansat,Ravi S. Keshari,(unknown),Cristina Lupu,Constantin Georgescu,Joe H. Simmons,Michael Wallisch,(unknown),Joseph J. Shatzel,Sven R. Olson,Christina U. Lorentz,Cristina Puy,Erik I. Tucker,David Gailani,Sidney Strickland,András Gruber,Owen J. T. McCarty,Florea Lupu	19
9	Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low‐density lipoprotein receptor‐deficient mice 2021 ·Journal of Thrombosis and Haemostasis ·Anh T. P. Ngo,Kelley R. Jordan,Paul Müeller,Matthew Hagen,Stéphanie E. Reitsma,Cristina Puy,Alexey S. Revenko,Christina U. Lorentz,Erik I. Tucker,(unknown),Monica T. Hinds,Sergio Fazio,Brett P. Monia,David Gailani,András Gruber,Hagai Tavori,Owen J. T. McCarty	28
10	The protein C activator AB002 rapidly interrupts thrombus development in baboons 2020 ·Blood ·Erik I. Tucker,Norah G. Verbout,Brandon D. Markway,Michael Wallisch,Christina U. Lorentz,Monica T. Hinds,Joseph J. Shatzel,Leslie A. Pelc,David C. Wood,Owen J. T. McCarty,Enrico Di,András Gruber	7
11	Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis 2020 ·Cellular and Molecular Bioengineering ·(unknown),Christina U. Lorentz,Jennifer Johnson,Cristina Puy,Sven R. Olson,Joseph J. Shatzel,David Gailani,Monica T. Hinds,Erik I. Tucker,András Gruber,Owen J. T. McCarty,Michael Wallisch	15
12	Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates 2020 ·Research and Practice in Thrombosis and Haemostasis ·Michael Wallisch,Christina U. Lorentz,(unknown),Jennifer Johnson,(unknown),Cristina Puy,David Gailani,Monica T. Hinds,Owen J. T. McCarty,András Gruber,Erik I. Tucker	41
13	The contact activation system as a potential therapeutic target in patients with COVID‐19 2020 ·Research and Practice in Thrombosis and Haemostasis ·Joseph J. Shatzel,(unknown),Christina U. Lorentz,Erik I. Tucker,Joseph E. Aslan,Monica T. Hinds,David Gailani,Jeffrey I. Weitz,Owen J. T. McCarty,András Gruber	32
14	Inhibition of contact-mediated activation of factor XI protects baboons against S aureus–induced organ damage and death 2019 ·Blood Advances ·Robert Silasi‐Mansat,Ravi S. Keshari,Cristina Lupu,Walter J. Janse van Rensburg,Hala Chaaban,(unknown),Aleksandr Shamanaev,Joseph J. Shatzel,Cristina Puy,Christina U. Lorentz,Erik I. Tucker,David Gailani,András Gruber,Owen J. T. McCarty,Florea Lupu	57
15	The Anti-Factor XII Antibody AB052 Is Antithrombotic without Hemostatic Impairment in a Primate Model of Extracorporeal Membrane Oxygenation 2017 ·Blood ·Michael Wallisch,Erik I. Tucker,Christina U. Lorentz,Jennifer Johnson,(unknown),Owen J. T. McCarty,Monica T. Hinds,András Gruber	4
16	Sympathetic denervation of peri-infarct myocardium requires the p75 neurotrophin receptor 2013 ·Experimental Neurology ·Christina U. Lorentz,(unknown),(unknown),(unknown),William R. Woodward,Barbara L. Hempstead,Beth A. Habecker	35
17	ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation 2012 ·The Journal of Experimental Medicine ·Chia-Jen Siao,Christina U. Lorentz,Pouneh Kermani,Tina Marinic,John Carter,Kevin McGrath,(unknown),Willie Mark,Domenick J. Falcone,Leona Cohen‐Gould,(unknown),Beth A. Habecker,Anders Nykjær,Lora H. Ellenson,Lino Tessarollo,Barbara L. Hempstead	68
18	Regulation of cardiac innervation and function via the p75 neurotrophin receptor 2008 ·Autonomic Neuroscience ·Beth A. Habecker,Parizad M. Bilimoria,(unknown),(unknown),Christina U. Lorentz,William R. Woodward,Susan J. Birren	26
19	Priming with BTCP, a dopamine reuptake blocker, reinstates cocaine-seeking and enhances cocaine cue-induced reinstatement 2005 ·Pharmacology Biochemistry and Behavior ·Rémi Martin‐Fardon,Christina U. Lorentz,(unknown),Friedbert Weiss	2
20	3-OH-pip-BTCP, a metabolite of the potent DA uptake blocker BTCP, exerts cocaine-like action in rats 2003 ·Neuroreport ·Rémi Martin‐Fardon,Christina U. Lorentz,Jean‐Marc Kamenka,Friedbert Weiss	1

About Christina U. Lorentz

Christina U. Lorentz is a scholar working on Hematology, Genetics and Internal Medicine, having authored 36 papers that have together received 728 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers) and Nerve injury and regeneration (5 papers). The work is most often cited by research in Genetics (298 citations), Hematology (276 citations) and Internal Medicine (66 citations). Christina U. Lorentz has collaborated with scholars based in United States, Canada and Denmark. Frequent co-authors include Erik I. Tucker, Owen J. T. McCarty, David Gailani, András Gruber, Beth A. Habecker, Monica T. Hinds, Joseph J. Shatzel, Cristina Puy, Michael Wallisch and Sven R. Olson. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact